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Sec14 is the major phosphatidylinositol (PtdIns)/phosphatidylcholine (PtdCho)
transfer protein in the yeast Saccharomyces cerevisiae and is the founding
member of the Sec14 protein superfamily. Recent functional data suggest that
Sec14 functions as a nanoreactor for PtdCho-regulated presentation of PtdIns
to PtdIns kinase to affect membrane trafficking. Extrapolation of this concept
to other members of the Sec14 superfamily suggests a mechanism by which a
comprehensive cohort of Sec14-like nanoreactors sense correspondingly diverse
pools of lipid metabolites. In turn, metabolic information is translated to
signaling circuits driven by phosphoinositide metabolism. Sfh3, one of five Sec14
homologs in yeast, exhibits several interesting functional features, including its
unique localization to lipid particles and microsomes. This localization forecasts
novel regulatory interfaces between neutral lipid metabolism and phosphoinosi-
tide signaling. To launch a detailed structural and functional characterization of
Sfh3, the recombinant protein was purified to homogeneity, diffraction-quality
crystals were produced and a native X-ray data set was collected to 2.2 Å
resolution. To aid in phasing, SAD X-ray diffraction data were collected to
1.93 Å resolution from an SeMet-labeled crystal at the Southeast Regional
Collaborative Access Team at the Advanced Photon Source. Here, the cloning
and purification of Sfh3 and the preliminary diffraction of Sfh3 crystals are
reported, enabling structural analyses that are expected to reveal novel principles
governing ligand binding and functional specificity for Sec14-superfamily
proteins.
1. Introduction
Membrane trafficking is central to cellular processes in eukaryotic
organisms. The Saccharomyces cerevisiae SEC14 gene product (Sec14)
is the founding member of the Sec14 superfamily of proteins, which
contains over 500 distinct proteins. It is the major phosphatidyl-
inositol (PtdIns)/phosphatidylcholine (PtdCho) transfer protein in
yeast and plays an essential role in stimulating protein transport from
the trans-Golgi network (Bankaitis et al., 1990). Sec14 proteins
coordinate critical aspects of lipid metabolism with the action of
proteins that catalyze the biogenesis of transport vesicles on the
trans-Golgi network and endosomal membranes (Cleves et al., 1991;
McGee et al., 1994; Xie et al., 1998; Li et al., 2002; Yanagisawa et al.,
2002; Bankaitis et al., 2010). Understanding the mechanics of how
Sec14-like proteins execute phospholipid (PL) exchange is of central
importance given that heterotypic PL-exchange reactions lie at the
heart of the mechanisms by which these proteins integrate lipid
metabolism with phosphoinositide (PIP) signaling (Schaaf et al., 2008;
Bankaitis et al., 2010).
Sfh3 (Sec 14 homolog 3) is only distantly related to Sec14, sharing
25% identity over essentially the entire primary sequence (Li et al.,
2000). Like Sec14, Sfh3 catalyzes PtdIns transfer. However, other
biological assays demonstrate that the functional properties of Sfh3
fundamentally differ from those of Sec14 (Li et al., 2000; Routt et al.,
2005). While Sfh3 is speculated to play a role in sterol biosynthesis
(Griac, 2007), the data to this effect are indirect and weak. Sfh3
localizes to lipid particles and microsomes; however, the function of
Sfh3 at these sites remains uncharacterized. The mechanisms which
functionally distinguish Sec14 from Sfh3 remain unknown.
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To investigate Sfh3 function from a structural perspective, we
purified Sfh3 and generated diffraction-quality crystals of both native
and SeMet-substituted proteins. Corresponding data sets were
collected at 2.2 and 1.93 Å, respectively. Experimental phasing of
SeMet-Sfh3 is under way. The Sfh3 structure is expected to reveal
new principles regarding the functional engineering of lipid-
metabolic nanoreactors of the Sec14 protein superfamily.
2. Materials and methods
2.1. Cloning and expression of recombinant Sfh3
DNA manipulations were carried out using standard protocols.
The entire SFH3 open-reading frame was amplified from yeast
genomic DNA by the polymerase chain reaction using 50-CGG-
ggtaccATGTTCAAGAGATTTAGCAAAAAG-30 and 50-CGGgag-
ctcTTACACGGTACTGCTTTCCG-30 as the forward and reverse
oligonucleotide primers, respectively. The amplified product was
adenine-tailed and incorporated into the pGEM-T Easy Vector
(Promega, Madison, Wisconsin, USA) following the manufacturer’s
instructions to generate plasmid pGEM-SFH3. To create an expres-
sion system for an octahistidine-tagged version of Sfh3 (His8-Sfh3),
the SFH3-coding region was excised from pGEM-SFH3 by digestion
with KpnI and SacI restriction endonucleases. The purified DNA
fragment was subcloned into a modified version of bacterial expres-
sion vector PET28b (Novagen, Madison, Wisconsin, USA) in which
an octahistidine-tag coding cassette followed by a KpnI site was
inserted into the unique NcoI site of the vector.
2.2. Protein purification and SeMet derivatization
The PET28-SFH3 construct was transferred into Escherichia coli
BL21-CodonPlus(DE3)-RIL cells (Stratagene, La Jolla, California,
USA). Protein expression was induced by the addition of 100 mM
IPTG to the growth medium and cultures were incubated for a
further 20 h at 289 K before harvesting cells. Cell-free lysates were
generated by lysozyme digestion followed by collisional disruption
with glass beads. Crude cell lysates were clarified by serial centrifu-
gation at 26 000g and 100 000g and the clarified supernatants were
incubated with Talon Co2+ resin (BD Biosciences Clontech) over-
night at 277 K with agitation. The Co2+ resin was collected by
centrifugation and thoroughly washed with lysis buffer (300 mM
NaCl, 50 mM sodium phosphate pH 7.5, 2 mM -mercaptoethanol)
supplemented with 5 mM imidazole. Bound proteins were eluted with
a linear 5–200 mM imidazole gradient and fractions containing His8-
Sfh3 were identified by SDS–PAGE and Coomassie staining. Peak
fractions were pooled and buffer-exchanged against lysis buffer to
remove imidazole. His8-Sfh3 was then concentrated to 8 mg ml
1.
Typically, we recovered 20 mg soluble His8-Sfh3 from a litre of
culture. The His8-Sfh3 protein was subjected to further purification
by Sephadex G200 gel-filtration chromatography prior to crystal-
lization trials.
Purification of SeMet-derivatized His8-Sfh3 essentially followed
the procedure described above. However, the E. coli methionine-
auxotrophic strain B834 was used as a production vehicle
(Hendrickson et al., 1990). Cells were cultured in medium containing
SeMet (Molecular Dimensions, UK) in lieu of methionine to effect
substitution.
2.3. Crystallization
Initial screening was performed at the Hauptman–Woodward
Medical Research Institute high-throughput screening laboratory
(Luft et al., 2003). Crystals began appearing after 24 h under a
number of conditions and these were subsequently optimized using
the sitting-drop vapor-diffusion method in 24-well VDX greased
plates (Hampton Research). The reservoir solution consisted of 15–
30% PEG 4000, 5% glycerol, 100 mM ammonium sulfate, 100 mM
ammonium acetate pH 5.6. Thin plate-like crystals were harvested 3–
4 d after mixing 2 ml protein solution (5 mg ml1) with 2 ml reservoir
solution.
2.4. X-ray data collection and processing
Sfh3 crystals were transferred to a cryoprotectant solution con-
taining 25%(v/v) glycerol and flash-cooled in liquid nitrogen prior
to diffraction data collection at 100 K on beamline 22-ID at the
Southeast Regional Collaborative Access Team (SER-CAT) facility
at the Advanced Photon Source (Argonne National Laboratory,
Argonne, Illinois, USA). A total of 360 images with an oscillation
range of 0.5 were collected from a single crystal at 100 K using a
beam size of 50  50 mm. A 2.2 Å resolution X-ray diffraction data
set was collected from a native Sfh3 crystal and processed in space
group P212121. A selenium single-wavelength anomalous dispersion
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Figure 1
Sequence alignment of Sec14-like proteins, with amino-acid residues which interact with PtdCho and PtdIns headgroups in Sfh1 (and Sec14) shaded pink and cyan,
respectively. Protein sequences were aligned using ClustalW2 (Chenna et al., 2003) on the EBI webserver using the Gonnet protein weight matrix. Gap-open and gap-
extension values were set to 10 and 0.1, respectively.
(SAD) data set was also collected to 1.93 Å resolution from an
SeMet-derivatized Sfh3 crystal at a wavelength of 0.97820 Å and
processed in space group P212121. Data were indexed, integrated and
scaled using HKL-2000 (Otwinowski & Minor, 1997). Calculation
of the self-rotation function was carried out using the program
MOLREP (Winn et al., 2011) and structure-factor amplitudes to a
maximum resolution of 4.0 Å. The native Patterson synthesis was
calculated using the program FFT (Winn et al., 2011).
3. Results and concluding remarks
S. cerevisiae Sec14 is the major yeast phosphatidylinositol (PtdIns)/
phosphatidylcholine (PtdCho) transfer protein and is the founding
member of the Sec14-protein superfamily. Structural studies revealed
that Sec14 binds its two phospholipid ligands (PtdIns and PtdCho)
at surprisingly distinct, but overlapping, binding sites (Schaaf et al.,
2008). Functional analyses further demonstrated that the capacity to
bind both PtdIns and PtdCho must be housed within a single protein
molecule in order to produce a biologically active Sec14 protein.
These data are interpreted in a PtdIns presentation model in which
Sec14 functions as a nanoreactor for PtdCho-regulated presentation
of PtdIns to PtdIns kinase. In this way, the Sec14 nanoreactor senses
PtdCho metabolism and translates it to phosphoinositide phosphate
(PIP) synthesis to regulate specific membrane-trafficking pathways.
Structure-based bioinformatics methods predict that the PtdIns-
binding site is conserved in the Sec14 superfamily, while the PtdCho-
binding site is missing from most of the Sec14-like proteins (Fig. 1).
While Sfh3 maintains the PtdIns-binding motif, it does not exhibit a
recognizable PtdCho-binding motif (Fig. 1). Specifically, Sec14 and
its closely related homolog Sfh1 utilize Tyr residues to stabilize the
positively charged PtdCho headgroup via cation– interactions
(Schaaf et al., 2008). Sfh3 contains Leu residues at these positions.
These substitutions, while not formally incompatible with PtdCho
coordination, are not predicted to favor burial of the choline moiety
deep within the hydrophobic protein core. The low sequence identity
that Sfh3 shares with Sec14, when coupled with its predicted lack of
PtdCho-binding ability, forecasts that Sfh3 will exhibit novel struc-
tural and functional features. Indeed, while Sfh3 is expected to
display the overall Sec14 (or CRAL-TRIO) architecture observed
in members of the Sec14 family of proteins, considerable structural
variation is observed across family members in the ‘gating helix’
which controls access to the phospholipid-binding pocket (Phillips et
al., 1999; Sha et al., 1998; Schaaf et al., 2008; Min et al., 2003; Meier et
al., 2003; Stocker & Baumann, 2003; D’Angelo et al., 2006; Welti et al.,
2007). Given its distinct cellular localization, it is possible that Sfh3
recognizes lipids beyond PtdIns. The identification of the second lipid
ligand other than PtdIns is pivotal to understanding the biological
function of proteins in the Sec14 superfamily. Crystallographic studies
are a critical first step towards the characterization of novel lipid–
Sfh3 interactions and the molecular mechanisms driving lipid binding
and exchange.
Sfh3 was purified to homogeneity by means of Co2+-affinity and
size-exclusion chromatography (Fig. 2). Crystallization proceeded
rapidly and thin plate-like crystals were harvested after 3–4 d (Fig. 3).
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Figure 2
Gel-filtration chromatogram of purified recombinant Sfh3 fractionated by
Sephadex G-200 size-exclusion chromatography. Elution profiles of the protein
markers BSA (67 kDa) and aldolase (158 kDa) are shown. Sfh3 (80 kDa) filters at a
position consistent with a dimer.
Figure 3
Three-dimensional plate-like crystals of Sfh3 grew from 15–30% PEG 4000, 5%
glycerol, 100 mM ammonium sulfate, 100 mM ammonium acetate pH 5.6.
Figure 4
X-ray diffraction image from a native Sfh3 crystal (0.5 oscillation) collected on
SER-CAT beamline 22-ID using a MAR CCD 300 detector at a wavelength of
1.0 Å. Diffraction extends to the detector edge, which corresponds to a resolution
of 1.85 Å.
Despite their non-ideal morphology, diffraction data were collected
to 2.2 Å resolution from these crystals. The X-ray diffraction data
set was processed in space group P212121, with unit-cell parameters
a = 52.65, b = 112.03, c = 144.91 Å (Fig. 4, Table 1). Systematic
absences for odd reflections in the cases of h00, 0k0 and 00l indicated
the presence of a 21 screw axis along all three axes. A self-rotation
function (Rossmann & Blow, 1962) calculated using 4 Å resolution
data in the  = 180 section showed strong pseudo-translation
together with peaks that correspond to three mutually orthogonal
twofold axes, suggesting that the asymmetric unit contains 222 point-
group symmetry (Fig. 5). However, no dominant features could be
assigned to noncrystallographic axes in the  = 180 section. The
observed heights of 3.75 and 3.31 for the corresponding self-
rotation peaks are much weaker than the height of 15.47 for the
origin peak and exceed the heights of all other peaks by less than
twofold. A Patterson function (Patterson, 1935) calculated using all
data showed a strong peak at 0.50, 0.50, 0.37, suggesting a dimer
(Fig. 6) in the asymmetric unit. The Matthews coefficient is
5.25 Å3 Da1 for one monomer in the asymmetric unit and
2.62 Å3 Da1 for two copies in the asymmetric unit, with solvent
contents of 76.6 and 53.2%, respectively. Gel-filtration and hydro-
dynamic analyses demonstrate that recombinant Sfh3 purifies as a
dimer (Fig. 2), suggesting that the asymmetric unit contains one copy
of the biologically relevant dimer.
Our efforts to phase the native Sfh3 data set by molecular
replacement failed using either the ‘open’ conformation of Sec14
(PDB entry 1aua; Sha et al., 1998) or the ‘closed’ conformation of
Sfh1 (PDB entries 3b74, 3b7n, 3b7q and 3b7z; Schaaf et al., 2008) as
search models. Thus, we expect that the conformation of Sfh3 is
sufficiently different from previously observed Sec14 structures to
prohibit molecular replacement. This intriguing possibility suggests
that solution of the Sfh3 structure will capture yet another func-
tionally important conformation for this class of PITPs.
To obtain experimental phase information, recombinant SeMet-
derivatized Sfh3 was purified from E. coli. Crystals were successfully
generated and diffracted to 1.93 Å resolution. A SAD data set was
collected to 1.93 Å resolution and processed in space group P212121,
with unit-cell parameters a = 52.52, b = 114.72, c = 144.69 Å (Fig. 4,
Table 1). The experimental phasing of Sfh3 is under way and we
expect that the forthcoming Sfh3 structure will reveal architectural
features that are unique to Sfh3. Such high-resolution information
will significantly extend our current understanding of the role of
Sec14-like proteins in lipid signaling.
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